FDA Adverse Event Malfunction Summary report: N

ALINITY HQ ANALYZER

MDR report key: 23873137 · Received December 22, 2025

Report

Report Number
2919069-2025-00053
Event Type
Malfunction
Date Received
December 22, 2025
Date of Event
December 9, 2025
Report Date
February 12, 2026
Manufacturer
ABBOTT LABORATORIES
Product Code
GKZ
UDI-DI
00380740138851
PMA / PMN Number
K220031
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
UK
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THE SERIAL NUMBER WAS CORRECTED. SEE SECTIONS D4 SERIAL NUMBER AND PRIMARY UDI NUMBER FOR CORRECTIONS.

Additional Manufacturer Narrative · 0

AN EVALUATION IS IN PROCESS. A FOLLOW-UP REPORT WILL BE SUBMITTED WHEN THE EVALUATION IS COMPLETE. A1 - PATIENT IDENTIFIER: (B)(6) (1PATIENT) / (B)(6) (2 DIFFERENT SAMPLES FROM SAME PATIENT) THIS EVENT HAS 2 TOTAL PATIENTS. ALL AVAILABLE PATIENT INFORMATION WAS INCLUDED. ADDITIONAL PATIENT DETAILS ARE NOT AVAILABLE. SEE RELATED MANUFACTURER REPORT 3004032053-2025-00024.

Additional Manufacturer Narrative · 0

THE ALINITY HQ ANALYZER, SERIAL # (B)(6) WAS EVALUATED, AND ANALYZER MAINTENANCE WAS COMPLETED. THE ANALYZER FUNCTION WAS VERIFIED WITH CONTROL TESTING. DATA AND INFORMATION PROVIDED BY THE CUSTOMER WERE REVIEWED AND SUPPORT THE COMPLAINT ISSUE WITHOUT INDICATION FOR ANY ADDITIONAL ISSUE. A REVIEW OF TRACKING AND TRENDING DID NOT IDENTIFY AN INCREASE IN COMPLAINT ACTIVITY FOR THE ALINITY HQ ANALYZER, SERIAL # (B)(6) WITH REGARDS TO THE CUSTOMER REPORTED EVENT. A REVIEW OF THE MANUFACTURING DOCUMENTATION DID NOT IDENTIFY ANY ISSUES FOR THE ALINITY HQ ANALYZER, SERIAL # (B)(6) AS IT RELATES TO THE CUSTOMER REPORTED EVENT. LABELING WAS REVIEWED AND WAS FOUND TO ADDRESS THE CUSTOMER REPORTED EVENT. BASED ON THE AVAILABLE INFORMATION, NO SYSTEMIC ISSUE OR DEFICIENCY WAS IDENTIFIED FOR THE ALINITY HQ ANALYZER, SERIAL # (B)(6).

Description of Event or Problem · 0

THE CUSTOMER OBSERVED FALSELY DECREASED HEMOGLOBIN RESULTS GENERATED ON THE ALINITY HQ PROCESSING MODULE FOR MULTIPLE PATIENTS. THE FOLLOWING DATA WAS PROVIDED (HEMOGLOBIN REFERENCE RANGE: 120¿160 G/L (12.0-16.0 G/DL): SAMPLE #1: (B)(6) FIRST RUN ON TITAN (B)(6) ON (B)(6) 2025 AT 02:00, SEQ 143689: HEMOGLOBIN = 65 G/L (6.5 G/DL) NO ERROR MESSAGES ATTACHED TO THIS RUN. AN ERROR MESSAGE OCCURRED AT 02:02: 3678 0 ATMOSPHERIC WASTE FULL. BACKGROUND CHECKS AT 02:03¿02:20, SEQ 143690¿143698, ALL FAILED WITH HIGH BACKGROUND COUNTS (WBC, RBC, HEMOGLOBIN, PLT, RETIC). ERROR MESSAGE WAS GENERATED: 1836-0 CBC RETIC BACKGROUND FAILED. THE FOLLOWING TROUBLESHOOTING WAS PERFORMED: DAILY AUTO CLEAN COMPLETED AT 02:49. BACKGROUNDS PASSED AFTERWARD. DAILY DRIFT CONTROL PASSED. ANOTHER 3678-0 ATMOSPHERIC WASTE FULL ERROR OCCURRED AT 02:39. A SECOND RUN OF SAMPLE (B)(6) AT 03:20, SEQ 143710, SHOWED A NORMALIZED VALUE: HEMOGLOBIN = 149 G/L (14.9 G/DL) THIS RESULT WAS NOT TRANSMITTED TO AMS; INITIAL LOW RESULT WAS COPIED INSTEAD. SAMPLE RERUN THREE TIMES ON DAY SHIFT (09:17, 09:24, 09:32, SEQ 143735, 143747, 143748): HEMOGLOBIN RESULT OF 148¿149 G/L (14.8-14.9 G/DL) EACH TIME. AGAIN, THESE RESULTS DID NOT TRANSMIT TO AMS, AND THE ORIGINAL FIRST RUN RESULTS WERE COPIED. SAMPLE RERUN ON ATLAS (B)(6) AT 09:37 (SEQ 176209, HEMOGLOBIN 153 G/L (15.3 G/DL)) AND 09:45 (SEQ 176212, HEMOGLOBIN 151 G/L (15.1 G/DL)) HEMOGLOBIN RESULT OF 65 G/L (6.5 G/DL) WAS REPORTED BUT LATER AMENDED. A SECOND SAMPLE FROM THE WARD ((B)(6), (B)(6) 2025 09:42) GENERATED A HEMOGLOBIN RESULT OF 149 G/L (14.9 G/DL), WHICH IS CONSISTENT WITH CORRECTED VALUES. SAMPLE #2: (B)(6) FIRST RUN ON TITAN (B)(6) 01:40, SEQ 143678: HEMOGLOBIN RESULT = 130 G/L (13.0 G/DL) BACKGROUNDS SEQ 143680¿687 PASSED. SECOND RUN AT 01:59, SEQ 143688, SHOWED SIGNIFICANTLY LOWER RESULTS: HEMOGLOBIN RESULT = 60.7 G/L (6.07 G/DL) THIS SAMPLE RUN WAS IN THE SAME BATCH AS SAMPLE (B)(6)¿S FIRST LOW RESULTS. THIRD RUN AFTER FAILED BACKGROUNDS AND DAILY WASH, AT 03:19, SEQ 143708: HEMOGLOBIN RESULT = 130 G/L (13.0 G/DL) THIS MATCHED THE FIRST RUN. AMS TRANSMISSION DETAILS NOT VISIBLE FOR THIS SAMPLE. A REPEAT SAMPLE (B)(6) AT 04:48 SHOWED A HEMOGLOBIN RESULT OF 129 G/L (12.9 G/DL), CONSISTENT WITH NORMAL RESULTS. THERE WAS NO IMPACT TO PATIENT MANAGEMENT REPORTED.

Description of Event or Problem · 0

THE CUSTOMER OBSERVED FALSELY DECREASED HEMOGLOBIN RESULTS GENERATED ON THE ALINITY HQ PROCESSING MODULE FOR MULTIPLE PATIENTS. THE FOLLOWING DATA WAS PROVIDED (HEMOGLOBIN REFERENCE RANGE: 120¿160 G/L (12.0-16.0 G/DL): SAMPLE #1: (B)(6) FIRST RUN ON TITAN (B)(6) ON (B)(6) 2025 AT 02:00, SEQ (B)(4): HEMOGLOBIN = 65 G/L (6.5 G/DL) NO ERROR MESSAGES ATTACHED TO THIS RUN. AN ERROR MESSAGE OCCURRED AT 02:02: 3678 0 ATMOSPHERIC WASTE FULL. BACKGROUND CHECKS AT 02:03¿02:20, SEQ (B)(4), ALL FAILED WITH HIGH BACKGROUND COUNTS (WBC, RBC, HEMOGLOBIN, PLT, RETIC). ERROR MESSAGE WAS GENERATED: 1836-0 CBC RETIC BACKGROUND FAILED. THE FOLLOWING TROUBLESHOOTING WAS PERFORMED: DAILY AUTO CLEAN COMPLETED AT 02:49. BACKGROUNDS PASSED AFTERWARD. DAILY DRIFT CONTROL PASSED. ANOTHER 3678-0 ATMOSPHERIC WASTE FULL ERROR OCCURRED AT 02:39. A SECOND RUN OF SAMPLE (B)(6) AT 03:20, SEQ 143710, SHOWED A NORMALIZED VALUE: HEMOGLOBIN = 149 G/L (14.9 G/DL) THIS RESULT WAS NOT TRANSMITTED TO AMS; INITIAL LOW RESULT WAS COPIED INSTEAD. SAMPLE RERUN THREE TIMES ON DAY SHIFT (09:17, 09:24, 09:32, SEQ (B)(4)): HEMOGLOBIN RESULT OF 148¿149 G/L (14.8-14.9 G/DL) EACH TIME. AGAIN, THESE RESULTS DID NOT TRANSMIT TO AMS, AND THE ORIGINAL FIRST RUN RESULTS WERE COPIED. SAMPLE RERUN ON ATLAS (B)(6) AT 09:37 (SEQ 176209, HEMOGLOBIN 153 G/L (15.3 G/DL)) AND 09:45 (SEQ 176212, HEMOGLOBIN 151 G/L (15.1 G/DL)) HEMOGLOBIN RESULT OF 65 G/L (6.5 G/DL) WAS REPORTED BUT LATER AMENDED. A SECOND SAMPLE FROM THE WARD ((B)(6), (B)(6) 2025 09:42) GENERATED A HEMOGLOBIN RESULT OF 149 G/L (14.9 G/DL), WHICH IS CONSISTENT WITH CORRECTED VALUES. SAMPLE #2: (B)(6) FIRST RUN ON TITAN (B)(6) 01:40, SEQ (B)(4): HEMOGLOBIN RESULT = 130 G/L (13.0 G/DL) BACKGROUNDS SEQ (B)(4) PASSED. SECOND RUN AT 01:59, SEQ (B)(4), SHOWED SIGNIFICANTLY LOWER RESULTS: HEMOGLOBIN RESULT = 60.7 G/L (6.07 G/DL) THIS SAMPLE RUN WAS IN THE SAME BATCH AS SAMPLE (B)(6)¿S FIRST LOW RESULTS. THIRD RUN AFTER FAILED BACKGROUNDS AND DAILY WASH, AT 03:19, SEQ (B)(4): HEMOGLOBIN RESULT = 130 G/L (13.0 G/DL) THIS MATCHED THE FIRST RUN. AMS TRANSMISSION DETAILS NOT VISIBLE FOR THIS SAMPLE. A REPEAT SAMPLE (B)(6) AT 04:48 SHOWED A HEMOGLOBIN RESULT OF 129 G/L (12.9 G/DL), CONSISTENT WITH NORMAL RESULTS. THERE WAS NO IMPACT TO PATIENT MANAGEMENT REPORTED.

Description of Event or Problem · 0

THE CUSTOMER OBSERVED FALSELY DECREASED HEMOGLOBIN RESULTS GENERATED ON THE ALINITY HQ PROCESSING MODULE FOR MULTIPLE PATIENTS. THE FOLLOWING DATA WAS PROVIDED (HEMOGLOBIN REFERENCE RANGE: 120¿160 G/L (12.0-16.0 G/DL): SAMPLE #1: (B)(6) FIRST RUN ON TITAN (B)(6) ON (B)(6) 2025 AT 02:00, SEQ 143689: HEMOGLOBIN = 65 G/L (6.5 G/DL) NO ERROR MESSAGES ATTACHED TO THIS RUN. AN ERROR MESSAGE OCCURRED AT 02:02: 3678 0 ATMOSPHERIC WASTE FULL. BACKGROUND CHECKS AT 02:03¿02:20, SEQ 143690¿143698, ALL FAILED WITH HIGH BACKGROUND COUNTS (WBC, RBC, HEMOGLOBIN, PLT, RETIC). ERROR MESSAGE WAS GENERATED: 1836-0 CBC RETIC BACKGROUND FAILED. THE FOLLOWING TROUBLESHOOTING WAS PERFORMED: DAILY AUTO CLEAN COMPLETED AT 02:49. BACKGROUNDS PASSED AFTERWARD. DAILY DRIFT CONTROL PASSED. ANOTHER 3678-0 ATMOSPHERIC WASTE FULL ERROR OCCURRED AT 02:39. A SECOND RUN OF SAMPLE (B)(6)5 AT 03:20, SEQ 143710, SHOWED A NORMALIZED VALUE: HEMOGLOBIN = 149 G/L (14.9 G/DL). THIS RESULT WAS NOT TRANSMITTED TO AMS; INITIAL LOW RESULT WAS COPIED INSTEAD. SAMPLE RERUN THREE TIMES ON DAY SHIFT (09:17, 09:24, 09:32, SEQ 143735, 143747, 143748): HEMOGLOBIN RESULT OF 148¿149 G/L (14.8-14.9 G/DL) EACH TIME. AGAIN, THESE RESULTS DID NOT TRANSMIT TO AMS, AND THE ORIGINAL FIRST RUN RESULTS WERE COPIED. SAMPLE RERUN ON ATLAS ((B)(6) AT 09:37 (SEQ 176209, HEMOGLOBIN 153 G/L (15.3 G/DL)) AND 09:45 (SEQ 176212, HEMOGLOBIN 151 G/L (15.1 G/DL)) HEMOGLOBIN RESULT OF 65 G/L (6.5 G/DL) WAS REPORTED BUT LATER AMENDED. A SECOND SAMPLE FROM THE WARD (B)(6) , (B)(6) 2025 09:42) GENERATED A HEMOGLOBIN RESULT OF 149 G/L (14.9 G/DL), WHICH IS CONSISTENT WITH CORRECTED VALUES. SAMPLE # 2: (B)(6). FIRST RUN ON TITAN (B)(6) 01:40, SEQ 143678: HEMOGLOBIN RESULT = 130 G/L (13.0 G/DL) BACKGROUNDS SEQ 143680¿687 PASSED. SECOND RUN AT 01:59, SEQ 143688, SHOWED SIGNIFICANTLY LOWER RESULTS: HEMOGLOBIN RESULT = 60.7 G/L (6.07 G/DL) THIS SAMPLE RUN WAS IN THE SAME BATCH AS SAMPLE (B)(6) FIRST LOW RESULTS. THIRD RUN AFTER FAILED BACKGROUNDS AND DAILY WASH, AT 03:19, SEQ 143708: HEMOGLOBIN RESULT = 130 G/L (13.0 G/DL) THIS MATCHED THE FIRST RUN. AMS TRANSMISSION DETAILS NOT VISIBLE FOR THIS SAMPLE. A REPEAT SAMPLE (B)(6) AT 04:48 SHOWED A HEMOGLOBIN RESULT OF 129 G/L (12.9 G/DL), CONSISTENT WITH NORMAL RESULTS. THERE WAS NO IMPACT TO PATIENT MANAGEMENT REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1565058 ALINITY HQ ANALYZER COUNTER, DIFFERENTIAL CELL GKZ ABBOTT LABORATORIES 00380740138851

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown